Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

BMO Capital Maintains Market Perform on Genpact, Lowers Price Target to $38

Author: Benzinga Newsdesk | May 10, 2024 11:17am
BMO Capital analyst Keith Bachman maintains Genpact (NYSE:G) with a Market Perform and lowers the price target from $39 to $38.

Posted In: G

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist